Inova Lung Services — Programs and Services — Pulmonary Hypertension Program
National expertise in managing pulmonary hypertension
Pulmonary hypertension (PH) refers to elevated pressure in the vessels of the lungs. If affected, the arteries and veins in the lungs become narrow and stiff. As the result, the right side of the heart has to work harder to pump blood through the lungs. If left untreated, PH can lead to right heart failure.
The Pulmonary Hypertension Program at Inova Fairfax Hospital provides the highly specialized multi-disciplinary care required by patients dealing with various types of PH. Inova's lung experts are nationally-recognized for their expertise in diagnosing, treating and managing PH, utilizing the most effective treatments available. Our program has long been recognized for its research of different forms of pulmonary hypertension.
Our Team
Our team is very active in pulmonary hypertension advocacy, fundraising and education. Read our most recent annual patient letter from program Director, Dr. Oksana Shlobin to learn more about what we do.
Accreditation affirms Inova's reputation as a PH expert
In September 2014, Inova's Pulmonary Hypertension Program was among the first six programs in the country to be accredited by the Pulmonary Hypertension Association (PHA) as a Comprehensive Care Center for Pulmonary Hypertension (CCC). Inova Fairfax served as the first pilot site to receive a site visit from PHA reviewers. The site visit was part of a nationwide accreditation effort by PHA to identify programs that provide the highest levels of expertise to effectively treat and manage pulmonary hypertension. This national designation identifies Inova Fairfax Hospital as one of the nation's premier providers of care for PH patients. Learn more about what it means to be a PH Care Center.
The PHA continues to acknowledge our team's vast experience and expertise. In October 2017, Dr. Shlobin, Pulmonary Hypertension Program Director, was invited to a two-year term on the PHA Scientific Leadership Council. She also serves on the PHA Oversight Committee. Dr. Shlobin routinely participates in the bi-annual PHA symposium and is a member of the PH council of The International Society For Heart and Lung Transplantation, as well as the Pulmonary Vascular Steering Committee for the American College of Chest Physicians (ACCP). Additionally, Dr.King serves on the Standards and Guidelines Committee for ACCP. Read more about our team.
Our Team in Action
Nurse coordinators Denise Lewis and Karen Brown participating in a walk to raise funds for Pulmonary Hypertension, as a part of the 2017 PHPN Symposium.
Nurse coordinators Angela Scully, Denise Lewis, and Karen Brown and Dr. Oksana Shlobin attend the 2018 PHA Symposium.
Dr. Oksana Shlobin presents to staffers of the House of Representatives during the 2018 PHA Advocacy Day.
Left to right: Dr.Weir, Denise Lewis, RN, Dr. Shlobin, and Karen Brown, RN, at Pulmonary Hypertension Education Day 2018.
Left to right: Dr. Psotka, Dr. Shlobin, Dr. Bogar, Dr.King, and Karen Brown, RN, at Pulmonary Hypertension Education Day 2018.
Left to right: Dr. Nathan, Dr. Shlobin, Dr. King and Dr. Brown at the PH Association walk on May 4, 2019. Inova's PHAngels team raised $5,100 in addition to Inova's event sponsorship.